About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« A Cure for the Common Cold? Don't. . .Ah, Hold Your Breath | Main | Heavy Atoms, Heavy Profits? »

February 16, 2009

Day Off

Email This Entry

Posted by Derek

Today is a holiday in many workplaces around the US today, and so it is at mine. I'm home at stately Lowe Manor, breaking ice off the shady front steps and cleaning out the cage of my daughter's guinea pig. The comparatively relaxing (and comparatively nice-smelling) business of drug discovery will resume tomorrow, as will blogging. See everyone then!

Comments (4) + TrackBacks (0) | Category: Blog Housekeeping


1. You're Pfizered on February 16, 2009 12:36 PM writes...

How many other places have today off? I'm slaving away! (when not whinnig about having to work...)

Permalink to Comment

2. Hap on February 16, 2009 1:09 PM writes...

Why doesn't your daughter get to clean out its cage? Litterboxes require much more regular maintenance - once a day they get cleaned out, though the cats aren't picky.

Permalink to Comment

3. Sili on February 16, 2009 2:37 PM writes...

I'm disappointed that a Levi fan doesn't have a snake to clean out after.

Permalink to Comment

4. SteveM on February 16, 2009 8:34 PM writes...

Re; "and comparatively nice-smelling) business of drug discovery."

I haven't done chemistry in a long time, but yeah I sorta liked the lab smells. Acetone, Ethyl Acetate, Ether (in moderation). The grassy smell of acid chlorides. The cherry smell of phenyl ketones. They were the sweet smells of what I did and enjoyed doing for a living.

Parenthetically, for a short period of time, the company hired a really good looking young woman to rotate through the labs and help clean up. And she wore this perfume called Raffine. That scent attached to that woman was absolutely intoxicating. All us meatball chemists would sidle up to to her in our lab coats and surreptitiously sniff. That was the best smell of all...

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry